These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2046275)

  • 41. [Nephrotic syndrome (clinico-morphological, immunological and biochemical aspects)].
    Riabov SI; Kozlov VV; Kozhevnikov AD; Rakitianskaia IA; Smirnov AV
    Ter Arkh; 1988; 60(6):24-8. PubMed ID: 3206362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [On the pathochemical characteristics of experimental nephrotic syndrome].
    Nikiforova NV
    Vopr Med Khim; 1967; 13(1):69-73. PubMed ID: 4178088
    [No Abstract]   [Full Text] [Related]  

  • 44. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A; Maíz A; Arteaga A
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hyperlipemia in the nephrotic syndrome. Study with intravenous triglycerides loading test].
    Chaptal J; Jean R; Crastes De Paulet A; Crastes De Paulet P; Astruc M
    Arch Fr Pediatr; 1969 Feb; 26(2):231. PubMed ID: 5375884
    [No Abstract]   [Full Text] [Related]  

  • 46. Lipid abnormalities in renal disease.
    Majumdar A; Wheeler DC
    J R Soc Med; 2000 Apr; 93(4):178-82. PubMed ID: 10844882
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of fibre in the treatment of secondary hyperlipidaemia in nephrotic patients.
    Gentile MG; Ciceri R; Manna GM; Delle Fave A; Zanoni C; Raschioni E; Combi S; Maiocchi V; D'Amico G
    Eur J Clin Nutr; 1995 Oct; 49 Suppl 3():S239-41. PubMed ID: 8549536
    [No Abstract]   [Full Text] [Related]  

  • 48. [Lipid metabolism disorders in nephrotic syndrome].
    Walasek L
    Pol Tyg Lek; 1973 Nov; 28(46):1824-6. PubMed ID: 4771863
    [No Abstract]   [Full Text] [Related]  

  • 49. Molecular mechanisms of lipid disorders in nephrotic syndrome.
    Vaziri ND
    Kidney Int; 2003 May; 63(5):1964-76. PubMed ID: 12675893
    [No Abstract]   [Full Text] [Related]  

  • 50. [Secondary hyperlipidemia in liver diseases].
    Baruch Y; Aviram M; Brook G
    Harefuah; 1983 Jan; 104(2):61-4. PubMed ID: 6873761
    [No Abstract]   [Full Text] [Related]  

  • 51. [Disorders of lipid metabolism in nephrotic syndrome].
    FRITEL D; LAGRUE G
    Rev Prat; 1959 Feb; 9(6):633-4 passim. PubMed ID: 13634808
    [No Abstract]   [Full Text] [Related]  

  • 52. [Physiopathology and clinical aspects of lipid metabolism disorders. Physiopathology of lipid metabolism from the clinical viewpoint].
    Haller H; Hanefeld M; Leonhardt W
    Dtsch Gesundheitsw; 1971 Sep; 26(36):1673-9. PubMed ID: 4940280
    [No Abstract]   [Full Text] [Related]  

  • 53. [Modifications of lipid and protein metabolism in the nephrotic syndrome].
    CAREDDU P
    Clin Radiol; 1960 Jul; 42():503-11. PubMed ID: 13690757
    [No Abstract]   [Full Text] [Related]  

  • 54. [Complications of nephrotic syndrome (NS) and the possibility of their treatment].
    Myśliwiec M
    Przegl Lek; 1992; 49(1-2):23-5. PubMed ID: 1280841
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum lipids in nephrotic syndrome.
    Banerjee SK; Sarkar AK; Chugh KS; Bansal VK; Chhuttani PN
    J Assoc Physicians India; 1972 Sep; 20(9):651-8. PubMed ID: 4654886
    [No Abstract]   [Full Text] [Related]  

  • 56. Complications of the nephrotic syndrome and their treatment.
    Crew RJ; Radhakrishnan J; Appel G
    Clin Nephrol; 2004 Oct; 62(4):245-59. PubMed ID: 15524054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Changes in the lipid metabolism in children with nephrotic syndrome].
    Matveev MP; Korovina NA
    Vopr Okhr Materin Det; 1968 Feb; 13(2):14-8. PubMed ID: 5720137
    [No Abstract]   [Full Text] [Related]  

  • 58. A physician's guide to hyperlipidemia.
    Fredrickson DS
    Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hyperlipidemia and nephropathy: cause or consequence?].
    Guijarro C; Keane WF
    Med Clin (Barc); 1995 Oct; 105(13):496-7. PubMed ID: 7494438
    [No Abstract]   [Full Text] [Related]  

  • 60. [Acquired atherogenic hyperlipoproteinemia].
    Guy-Grand B; Bigorie B
    Coeur Med Interne; 1973 Oct; 12(4):491-6. PubMed ID: 4794181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.